全文获取类型
收费全文 | 40444篇 |
免费 | 2783篇 |
国内免费 | 138篇 |
专业分类
耳鼻咽喉 | 493篇 |
儿科学 | 897篇 |
妇产科学 | 795篇 |
基础医学 | 4841篇 |
口腔科学 | 1049篇 |
临床医学 | 4301篇 |
内科学 | 8380篇 |
皮肤病学 | 421篇 |
神经病学 | 3491篇 |
特种医学 | 1369篇 |
外国民族医学 | 1篇 |
外科学 | 6860篇 |
综合类 | 559篇 |
一般理论 | 28篇 |
预防医学 | 3328篇 |
眼科学 | 1204篇 |
药学 | 2579篇 |
中国医学 | 39篇 |
肿瘤学 | 2730篇 |
出版年
2023年 | 170篇 |
2022年 | 253篇 |
2021年 | 731篇 |
2020年 | 454篇 |
2019年 | 665篇 |
2018年 | 804篇 |
2017年 | 586篇 |
2016年 | 672篇 |
2015年 | 804篇 |
2014年 | 1155篇 |
2013年 | 1782篇 |
2012年 | 2540篇 |
2011年 | 2639篇 |
2010年 | 1494篇 |
2009年 | 1401篇 |
2008年 | 2403篇 |
2007年 | 2507篇 |
2006年 | 2498篇 |
2005年 | 2676篇 |
2004年 | 2576篇 |
2003年 | 2362篇 |
2002年 | 2230篇 |
2001年 | 357篇 |
2000年 | 272篇 |
1999年 | 418篇 |
1998年 | 531篇 |
1997年 | 429篇 |
1996年 | 369篇 |
1995年 | 363篇 |
1994年 | 296篇 |
1993年 | 272篇 |
1992年 | 245篇 |
1991年 | 230篇 |
1990年 | 201篇 |
1989年 | 181篇 |
1988年 | 170篇 |
1987年 | 186篇 |
1986年 | 177篇 |
1985年 | 209篇 |
1984年 | 290篇 |
1983年 | 271篇 |
1982年 | 391篇 |
1981年 | 339篇 |
1980年 | 312篇 |
1979年 | 175篇 |
1978年 | 208篇 |
1977年 | 210篇 |
1976年 | 204篇 |
1975年 | 161篇 |
1973年 | 155篇 |
排序方式: 共有10000条查询结果,搜索用时 140 毫秒
1.
2.
The human visual system is amenable to a number of adaptive processes; one such process, or collection of processes, is the adaptation to blur. Blur adaptation can be observed as an improvement in vision under degraded conditions, and these changes occur relatively rapidly following exposure to blur. The potential important future directions of this research area and the clinical implications of blur adaptation are discussed. 相似文献
3.
4.
5.
Edward J. Holland Walter O. Whitley Kenneth Sall Stephen S. Lane Aparna Raychaudhuri Steven Y. Zhang 《Current medical research and opinion》2016,32(10):1759-1765
Objective: Report efficacy findings from three clinical trials (one phase 2 and two phase 3 [OPUS-1, OPUS-2]) of lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease (DED).Research design and methods: Three 84-day, randomized, double-masked, placebo-controlled trials. Adults (≥18 years) with DED were randomized (1:1) to lifitegrast 5.0% or matching placebo. Changes from baseline to day 84 in signs and symptoms of DED were analyzed.Main outcome measures: Phase 2, pre-specified endpoint: inferior corneal staining score (ICSS; 0–4); OPUS-1, coprimary endpoints: ICSS and visual-related function subscale (0–4 scale); OPUS-2, coprimary endpoints: ICSS and eye dryness score (EDS, VAS; 0–100).Results: Fifty-eight participants were randomized to lifitegrast 5.0% and 58 to placebo in the phase 2 trial; 293 to lifitegrast and 295 to placebo in OPUS-1; 358 to lifitegrast and 360 to placebo in OPUS-2. In participants with mild-to-moderate baseline DED symptomatology, lifitegrast improved ICSS versus placebo in the phase 2 study (treatment effect, 0.35; 95% CI, 0.05–0.65; p?=?0.0209) and OPUS-1 (effect, 0.24; 95% CI, 0.10–0.38; p?=?0.0007). Among more symptomatic participants (baseline EDS ≥40, recent artificial tear use), lifitegrast improved EDS versus placebo in a post hoc analysis of OPUS-1 (effect, 13.34; 95% CI, 2.35–24.33; nominal p?=?0.0178) and in OPUS-2 (effect, 12.61; 95% CI, 8.51–16.70; p?<?0.0001).Limitations: Trials were conducted over 12 weeks; efficacy beyond this period was not assessed.Conclusions: Across three trials, lifitegrast improved ICSS in participants with mild-to-moderate baseline symptomatology in two studies, and EDS in participants with moderate-to-severe baseline symptomatology in two studies. Based on the overall findings from these trials, lifitegrast shows promise as a new treatment option for signs and symptoms of DED. 相似文献
6.
7.
8.
Elissa A. Adame Ryan S. Bisel Edward S. Kosik Julia A. Rygaard 《Health communication》2019,34(6):638-643
An essential piece of anesthesiologist training is attending resident feedback sessions. Yet, few attending anesthesiologists have formal teaching education and little time to acquire it. In this field experiment, attending physicians were randomly assigned to a control group or to receive 30 minutes of feedback training inspired by Implicit Person Theory (IPT). As such, IPT training encouraged physicians to praise process-oriented learning while discouraging performance-oriented mindsets. Attending physicians then observed residents participate in a human patient simulation (HPS) activity and provided residents with feedback. Content and statistical analyses revealed trained attending physicians praised learning goals and challenged performance goals more often than untrained physicians during feedback sessions. Thus, the training provides a rapid method of enhancing the quality of attending physicians’ training communication. 相似文献
9.
Anastasiia Panfilova Sarah E. Shelton Cristina Caresio Ruud J.G. van Sloun Filippo Molinari Hessel Wijkstra Paul A. Dayton Massimo Mischi 《Ultrasound in medicine & biology》2019,45(2):539-548
Dynamic contrast-enhanced ultrasound (DCE-US) has been proposed as a powerful tool for cancer diagnosis by estimation of perfusion and dispersion parameters reflecting angiogenic vascular changes. This work was aimed at identifying which vascular features are reflected by the estimated perfusion and dispersion parameters through comparison with acoustic angiography (AA). AA is a high-resolution technique that allows quantification of vascular morphology. Three-dimensional AA and 2-D DCE-US bolus acquisitions were used to monitor the growth of fibrosarcoma tumors in nine rats. AA-derived vascular properties were analyzed along with DCE-US perfusion and dispersion to investigate the differences between tumor and control and their evolution in time. AA-derived microvascular density and DCE-US perfusion exhibited good agreement, confirmed by their spatial distributions. No vascular feature was correlated with dispersion. Yet, dispersion provided better cancer classification than perfusion. We therefore hypothesize that dispersion characterizes vessels that are smaller than those visible with AA. 相似文献
10.
Leyi Wang Saraswathi Lanka Debbie Cassout Nohra E. Mateus‐Pinilla Ganwu Li William C. Wilson Dongwan Yoo Paul Shelton Richard L. Fredrickson 《Transboundary and Emerging Diseases》2019,66(5):1809-1820
First described in 1955 in New Jersey, epizootic haemorrhagic disease (EHD) causes a severe clinical disease in wild and domestic ruminants worldwide. Epizootic haemorrhagic disease outbreaks occur in deer populations each year from summer to late autumn. The etiological agent is EHD virus (EHDV) which is a double‐stranded segmented icosahedral RNA virus. EHD virus utilizes point mutations and reassortment strategies to maintain viral fitness during infection. In 2018, EHDV serotype 2 was predominantly detected in deer in Illinois. Whole genome sequencing was conducted for two 2018 EHDV2 isolates (IL41747 and IL42218) and the sequence analyses indicated that IL42218 was a reassortant between different serotypes whereas IL41747 was a genetically stable strain. Our data suggest that multiple strains contribute to outbreaks each year. 相似文献